医药-话题@MedSci

#医药#

1668篇内容 | 2720人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1410185, encodeId=3f7c1410185ad, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=铨景式临床研究信息化解决方案提供商——铨融医药科技完成数千万元B轮融资，凯乘资本继续担任独家财务顾问, objectType=article, longId=220157, objectId=f41822015e31, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f41822015e31, replyNumber=0, likeNumber=71, createdTime=2021-11-13, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f41822015e31, moduleTitle=铨景式临床研究信息化解决方案提供商——铨融医药科技完成数千万元B轮融资，凯乘资本继续担任独家财务顾问, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f41822015e31)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410184, encodeId=2d8c1410184d2, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=博生吉医药CD7靶向CAR-T细胞注射液获得美国FDA孤儿药资格认定, objectType=article, longId=220150, objectId=4aba220150d9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4aba220150d9, replyNumber=0, likeNumber=86, createdTime=2021-11-13, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4aba220150d9, moduleTitle=博生吉医药CD7靶向CAR-T细胞注射液获得美国FDA孤儿药资格认定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4aba220150d9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410183, encodeId=0f7414101831e, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=2021年11月9日简报：日本15个月来，首次无单日新增新冠死亡病例；新加坡要求拒绝接种新冠疫苗者染病后自付医药费；泰国重开国门满7天超2万人入境，其中发现15例新冠确诊病例；新冠后遗症需要引起关注, objectType=article, longId=220018, objectId=623e22001886, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=623e22001886, replyNumber=0, likeNumber=61, createdTime=2021-11-10, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=623e22001886, moduleTitle=2021年11月9日简报：日本15个月来，首次无单日新增新冠死亡病例；新加坡要求拒绝接种新冠疫苗者染病后自付医药费；泰国重开国门满7天超2万人入境，其中发现15例新冠确诊病例；新冠后遗症需要引起关注, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=623e22001886)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410182, encodeId=5a2a141018244, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=先通医药完成3.2亿元D+轮融资，国寿大健康基金和大钲资本共同投资 , objectType=article, longId=219022, objectId=804621902279, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=804621902279, replyNumber=0, likeNumber=29, createdTime=2021-10-23, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=804621902279, moduleTitle=先通医药完成3.2亿元D+轮融资，国寿大健康基金和大钲资本共同投资 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=804621902279)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410181, encodeId=dfb91410181de, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=美国阿南达医药科技（ANANDA Scientific）采用了Liquid Structure™技术的大麻二酚(CBD)将接受用于治疗阿片类用药障碍的临床评估, objectType=article, longId=218932, objectId=e31c21893241, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e31c21893241, replyNumber=0, likeNumber=67, createdTime=2021-10-22, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e31c21893241, moduleTitle=美国阿南达医药科技（ANANDA Scientific）采用了Liquid Structure™技术的大麻二酚(CBD)将接受用于治疗阿片类用药障碍的临床评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e31c21893241)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410180, encodeId=c4dd141018077, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=国务院印发深化医改的实施意见，医药板块重挫, objectType=article, longId=218827, objectId=023c21882e0a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=023c21882e0a, replyNumber=0, likeNumber=63, createdTime=2021-10-20, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=023c21882e0a, moduleTitle=国务院印发深化医改的实施意见，医药板块重挫, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=023c21882e0a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410179, encodeId=7a7614101e9aa, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=梅斯医学荣获2021中国数字医疗企业百强榜医药数字化企业TOP10, objectType=article, longId=218503, objectId=081a2185038a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=081a2185038a, replyNumber=0, likeNumber=67, createdTime=2021-10-14, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=081a2185038a, moduleTitle=梅斯医学荣获2021中国数字医疗企业百强榜医药数字化企业TOP10, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=081a2185038a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410176, encodeId=970e14101e66b, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=替代疗法：中医药治疗铜绿假单胞菌感染, objectType=article, longId=218245, objectId=fc4a218245e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fc4a218245e9, replyNumber=0, likeNumber=102, createdTime=2021-10-10, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fc4a218245e9, moduleTitle=替代疗法：中医药治疗铜绿假单胞菌感染, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fc4a218245e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410175, encodeId=f3c414101e57f, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=国家药监局批准恒瑞医药普瑞巴林缓释片用于治疗成人慢性神经性疼痛, objectType=article, longId=217887, objectId=252921e88739, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=252921e88739, replyNumber=0, likeNumber=77, createdTime=2021-10-01, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=252921e88739, moduleTitle=国家药监局批准恒瑞医药普瑞巴林缓释片用于治疗成人慢性神经性疼痛, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=252921e88739)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410174, encodeId=c83514101e43b, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=2021上海国际生物医药产业周在即，大会亮点抢先看, objectType=article, longId=217787, objectId=384721e7876c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=384721e7876c, replyNumber=0, likeNumber=79, createdTime=2021-09-29, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=384721e7876c, moduleTitle=2021上海国际生物医药产业周在即，大会亮点抢先看, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=384721e7876c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410173, encodeId=2e9914101e389, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=纳入优先审评！恒瑞医药创新药吡咯替尼新适应症——新辅助治疗, objectType=article, longId=217708, objectId=bfcd21e7083b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bfcd21e7083b, replyNumber=0, likeNumber=64, createdTime=2021-09-28, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bfcd21e7083b, moduleTitle=纳入优先审评！恒瑞医药创新药吡咯替尼新适应症——新辅助治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bfcd21e7083b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410172, encodeId=af1814101e284, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=Frontiers pharmacol：中医药治疗抑郁症合并糖尿病前景光明, objectType=article, longId=217602, objectId=1aa221e602d9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1aa221e602d9, replyNumber=0, likeNumber=70, createdTime=2021-09-26, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1aa221e602d9, moduleTitle=Frontiers pharmacol：中医药治疗抑郁症合并糖尿病前景光明, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1aa221e602d9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410171, encodeId=817214101e1c5, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=亚盛医药alrizomadlin（APG-115）治疗黑色素瘤获美国FDA快速通道资格, objectType=article, longId=217535, objectId=f52621e5352b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f52621e5352b, replyNumber=0, likeNumber=72, createdTime=2021-09-25, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f52621e5352b, moduleTitle=亚盛医药alrizomadlin（APG-115）治疗黑色素瘤获美国FDA快速通道资格, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f52621e5352b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410170, encodeId=647914101e0dd, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=共济未来，驱动新生 2021上海国际生物医药产业周新闻通气会, objectType=article, longId=217434, objectId=38e621e4347e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=38e621e4347e, replyNumber=0, likeNumber=53, createdTime=2021-09-24, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=38e621e4347e, moduleTitle=共济未来，驱动新生 2021上海国际生物医药产业周新闻通气会, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=38e621e4347e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410169, encodeId=18ae1410169fb, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=TCMIVD：传统医学带来新期待——中医药干预血管性痴呆, objectType=article, longId=217232, objectId=5b7721e23291, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5b7721e23291, replyNumber=0, likeNumber=120, createdTime=2021-09-18, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5b7721e23291, moduleTitle=TCMIVD：传统医学带来新期待——中医药干预血管性痴呆, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5b7721e23291)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410168, encodeId=b68714101683b, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=梅斯医学与博生吉医药科技达成战略合作，共同推动中国细胞治疗技术的发展, objectType=article, longId=217171, objectId=d54a21e1711a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d54a21e1711a, replyNumber=0, likeNumber=65, createdTime=2021-09-17, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d54a21e1711a, moduleTitle=梅斯医学与博生吉医药科技达成战略合作，共同推动中国细胞治疗技术的发展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d54a21e1711a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410167, encodeId=f4a4141016edd, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=BP：中医药可辅助治疗肺癌, objectType=article, longId=216925, objectId=daeb21692541, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=daeb21692541, replyNumber=0, likeNumber=106, createdTime=2021-09-12, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=daeb21692541, moduleTitle=BP：中医药可辅助治疗肺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=daeb21692541)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410166, encodeId=77d3141016633, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=分子和治疗视角下：中医药治疗非酒精性脂肪性肝病, objectType=article, longId=216650, objectId=8672216650b1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8672216650b1, replyNumber=0, likeNumber=87, createdTime=2021-09-04, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8672216650b1, moduleTitle=分子和治疗视角下：中医药治疗非酒精性脂肪性肝病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8672216650b1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410165, encodeId=6847141016507, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=信达生物与劲方医药关于GFH925（KRAS G12C抑制剂）达成全球战略合作, objectType=article, longId=216609, objectId=cb44216609d0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cb44216609d0, replyNumber=0, likeNumber=0, createdTime=2021-09-04, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cb44216609d0, moduleTitle=信达生物与劲方医药关于GFH925（KRAS G12C抑制剂）达成全球战略合作, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cb44216609d0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410164, encodeId=60921410164cf, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=勤浩医药SHP2抑制剂GH21完成中美双报IND, objectType=article, longId=216513, objectId=c0e7216513c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c0e7216513c3, replyNumber=0, likeNumber=61, createdTime=2021-09-02, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c0e7216513c3, moduleTitle=勤浩医药SHP2抑制剂GH21完成中美双报IND, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c0e7216513c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

医药

2020-05-29

cathymary (审核中...)

前往app查看评论内容

#医药#

铨景式临床研究信息化解决方案提供商——铨融医药科技完成数千万元B轮融资，凯乘资本继续担任独家财务顾问

2021-11-13

cathymary (审核中...)

前往app查看评论内容

#医药#

博生吉医药CD7靶向CAR-T细胞注射液获得美国FDA孤儿药资格认定

2021-11-13

cathymary (审核中...)

前往app查看评论内容

#医药#

2021年11月9日简报：日本15个月来，首次无单日新增新冠死亡病例；新加坡要求拒绝接种新冠疫苗者染病后自付医药费；泰国重开国门满7天超2万人入境，其中发现15例新冠确诊病例；新冠后遗症需要引起关注

2021-11-10

cathymary (审核中...)

前往app查看评论内容

#医药#

先通医药完成3.2亿元D+轮融资，国寿大健康基金和大钲资本共同投资

2021-10-23

cathymary (审核中...)

前往app查看评论内容

#医药#

美国阿南达医药科技（ANANDA Scientific）采用了Liquid Structure™技术的大麻二酚(CBD)将接受用于治疗阿片类用药障碍的临床评估

2021-10-22

cathymary (审核中...)

前往app查看评论内容

#医药#

国务院印发深化医改的实施意见，医药板块重挫

2021-10-20

cathymary (审核中...)

前往app查看评论内容

#医药#

梅斯医学荣获2021中国数字医疗企业百强榜医药数字化企业TOP10

2021-10-14

cathymary (审核中...)

前往app查看评论内容

#医药#

替代疗法：中医药治疗铜绿假单胞菌感染

2021-10-10

cathymary (审核中...)

前往app查看评论内容

#医药#

国家药监局批准恒瑞医药普瑞巴林缓释片用于治疗成人慢性神经性疼痛

2021-10-01

cathymary (审核中...)

前往app查看评论内容

#医药#

2021上海国际生物医药产业周在即，大会亮点抢先看

2021-09-29

cathymary (审核中...)

前往app查看评论内容

#医药#

纳入优先审评！恒瑞医药创新药吡咯替尼新适应症——新辅助治疗

2021-09-28

cathymary (审核中...)

前往app查看评论内容

#医药#

Frontiers pharmacol：中医药治疗抑郁症合并糖尿病前景光明

2021-09-26

cathymary (审核中...)

前往app查看评论内容

#医药#

亚盛医药alrizomadlin（APG-115）治疗黑色素瘤获美国FDA快速通道资格

2021-09-25

cathymary (审核中...)

前往app查看评论内容

#医药#

共济未来，驱动新生 2021上海国际生物医药产业周新闻通气会

2021-09-24

cathymary (审核中...)

前往app查看评论内容

#医药#

TCMIVD：传统医学带来新期待——中医药干预血管性痴呆

2021-09-18

cathymary (审核中...)

前往app查看评论内容

#医药#

梅斯医学与博生吉医药科技达成战略合作，共同推动中国细胞治疗技术的发展

2021-09-17

cathymary (审核中...)

前往app查看评论内容

#医药#

BP：中医药可辅助治疗肺癌

2021-09-12

cathymary (审核中...)

前往app查看评论内容

#医药#

分子和治疗视角下：中医药治疗非酒精性脂肪性肝病

2021-09-04

cathymary (审核中...)

前往app查看评论内容

#医药#

信达生物与劲方医药关于GFH925（KRAS G12C抑制剂）达成全球战略合作

2021-09-04

cathymary (审核中...)

前往app查看评论内容

#医药#

勤浩医药SHP2抑制剂GH21完成中美双报IND

2021-09-02

科室
- - 订阅+
  - 更多科室
工具
服务